Contineum Therapeutics

Developer of small molecule therapies for neurology and immunological diseases

placeSan Diego, California, United States calendar_todayFounded 2017 groups14 employees language contineum-tx.com

Registered entities

Innovation

8 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 396 times.

YearFilings
20211
20221
20232
20243
20258
20261

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon